Viewing StudyNCT01639001



Ignite Creation Date: 2024-05-06 @ 12:40 AM
Last Modification Date: 2024-10-26 @ 10:53 AM
Study NCT ID: NCT01639001
Status: COMPLETED
Last Update Posted: 2020-12-08
First Post: 2012-07-10

Brief Title: A Study Of Crizotinib Versus Chemotherapy In Previously Untreated ALK Positive East Asian Non-Small Cell Lung Cancer Patients
Sponsor: Pfizer
Organization: Pfizer

Conditions & Keywords Data

Conditions:
Name
NSCLC Non-small Cell Lung Cancer
Keywords:
Name View
Non-Squamous View
Crizotinib View
ALK positive View
ALK View
Anaplastic Lymphoma Kinase View
NSCLC View
Non-Small Cell Lung Cancer View
Frontline View
1L View
Previously Untreated View
East Asian View